Literature DB >> 21109638

Drug research. Roche exits RNAi field, cuts 4800 jobs.

Jennifer Couzin-Frankel.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21109638     DOI： 10.1126/science.330.6008.1163

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

1.  Is silence still golden? Mapping the RNAi patent landscape.

Authors:  Per Lundin
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

2.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

Review 3.  RNA therapeutics: beyond RNA interference and antisense oligonucleotides.

Authors:  Ryszard Kole; Adrian R Krainer; Sidney Altman
Journal:  Nat Rev Drug Discov       Date:  2012-01-20       Impact factor: 84.694

4.  The effectiveness of RNAi in Caenorhabditis elegans is maintained during spaceflight.

Authors:  Timothy Etheridge; Kanako Nemoto; Toko Hashizume; Chihiro Mori; Tomoko Sugimoto; Hiromi Suzuki; Keiji Fukui; Takashi Yamazaki; Akira Higashibata; Nathaniel J Szewczyk; Atsushi Higashitani
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

Review 5.  Antiviral RNAi: translating science towards therapeutic success.

Authors:  Priya S Shah; David V Schaffer
Journal:  Pharm Res       Date:  2011-08-09       Impact factor: 4.200

6.  Neutrophils preferentially phagocytose elongated particles-An opportunity for selective targeting in acute inflammatory diseases.

Authors:  Hanieh Safari; William J Kelley; Eiji Saito; Nicholas Kaczorowski; Lauren Carethers; Lonnie D Shea; Omolola Eniola-Adefeso
Journal:  Sci Adv       Date:  2020-06-10       Impact factor: 14.136

7.  Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma.

Authors:  Jing Lin; Jia Hui Jane Lee; Kathirvel Paramasivam; Elina Pathak; Zhenxun Wang; Zacharias Aloysius Dwi Pramono; Bing Lim; Keng Boon Wee; Uttam Surana
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.